RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+30.2%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$166M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1 +$17.2M
2 +$13.3M
3 +$11.4M
4
NUVL icon
Nuvalent
NUVL
+$10.9M
5
VERA icon
Vera Therapeutics
VERA
+$10.3M

Top Sells

1 +$19M
2 +$14.8M
3 +$13.2M
4
CYTK icon
Cytokinetics
CYTK
+$13.1M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$11.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCUL icon
76
Ocular Therapeutix
OCUL
$1.81B
$3.22M 0.3%
265,000
+63,000
ASND icon
77
Ascendis Pharma A/S
ASND
$13B
$3.2M 0.3%
+15,000
JANX icon
78
Janux Therapeutics
JANX
$815M
$3.11M 0.29%
225,377
+125,250
PRVA icon
79
Privia Health
PRVA
$2.73B
$2.96M 0.28%
125,000
-69,189
STVN icon
80
Stevanato
STVN
$5.04B
$2.96M 0.28%
147,025
+96,025
VKTX icon
81
Viking Therapeutics
VKTX
$3.3B
$2.92M 0.27%
83,000
-133,288
CYTK icon
82
Cytokinetics
CYTK
$9.7B
$2.82M 0.26%
44,375
-210,875
A icon
83
Agilent Technologies
A
$38.3B
$2.72M 0.25%
+20,000
XNCR icon
84
Xencor
XNCR
$873M
$2.54M 0.24%
165,750
CNTA
85
Centessa Pharmaceuticals
CNTA
$6.13B
$2.5M 0.23%
+100,000
TGTX icon
86
TG Therapeutics
TGTX
$6.15B
$2.18M 0.2%
73,250
-19,750
BNTX icon
87
BioNTech
BNTX
$22.3B
$1.99M 0.19%
20,870
-15,000
WST icon
88
West Pharmaceutical
WST
$22.2B
$1.93M 0.18%
+7,000
CNC icon
89
Centene
CNC
$30.8B
$1.9M 0.18%
46,231
-123,769
QURE icon
90
uniQure
QURE
$1.67B
$1.9M 0.18%
+79,375
DNLI icon
91
Denali Therapeutics
DNLI
$3.1B
$1.65M 0.15%
100,000
STE icon
92
Steris
STE
$20.7B
$1.52M 0.14%
+6,000
IRTC icon
93
iRhythm Holdings
IRTC
$3.55B
$1.24M 0.12%
7,000
ATEC icon
94
Alphatec Holdings
ATEC
$1.23B
$421K 0.04%
20,000
+2,000
ABT icon
95
Abbott
ABT
$159B
-98,500
AKRO
96
DELISTED
Akero Therapeutics
AKRO
-230,600
ANNX icon
97
Annexon
ANNX
$867M
-823,000
CAH icon
98
Cardinal Health
CAH
$48.2B
-94,000
DVAX
99
DELISTED
Dynavax Technologies
DVAX
-772,000
EXAS
100
DELISTED
Exact Sciences
EXAS
-348,000